Instrument | Initial | 15-wk | 12-, 18-, 24-, 30- 36-months |
---|---|---|---|
Tobacco Use | Â | Â | Â |
Opiate Treatment Index (OTI, quantity/frequency) [14] | √ | √ | √ |
Point Prevalence and Continuous Abstinence | √ | √ | √ |
Readiness to Quit Smoking [15] | √ | - | - |
Fagerstrom Test for Nicotine Dependence [16] | √ | √ | √ |
Expired Carbon Monoxide | √ | √ | √ |
Minnesota Nicotine Withdrawal Scale (MNWS-R)[17] | √ | √ | √ |
Physical Activity | Â | Â | Â |
Readiness to change physical activity [18] | √ | - | - |
Physical activity screen (past week) | √ | √ | √ |
Average minutes walking per week | √ | √ | √ |
International Physical Activity Questionnaire [19] | √ | √ | √ |
Dietary Habits | Â | Â | Â |
Readiness to change eating habits | √ | - | - |
24-hour recall of eating patterns | √ | √ | √ |
Other CVD Risk Factors | Â | Â | Â |
OTI- alcohol and cannabis | √ | √ | √ |
Beck Depression Inventory - II [20] | √ | √ | √ |
Brief Symptom Inventory [21] | √ | √ | √ |
Body mass index (height, weight) | √ | √ | √ |
Waist-hip ratio (cms) | √ | √ | √ |
Auscultatory Blood pressure | √ | √ | √ |
Fingerprick Blood Tests (glucose, cholesterol, lipids) | √ | √ | √ |
Treatment and Service Utilisation [22] | √ | √ | √ |
Diagnosis of psychosis and Symptom Measure | Â | Â | Â |
Brief Psychiatric Rating Scale [23] | √ | √ | √ |
Mini International Neuropsychiatric Interview [22] | √ | - | - |
Functioning | Â | Â | Â |
Global Assessment of Functioning [24] | √ | √ | √ |
Medical Outcome Survey SF-36 [25] | √ | √ | √ |
Quality of Life Scale [26] | √ | √ | √ |
Impact of Weight on Quality of Life Questionnaire [27] | √ | √ | √ |
Therapeutic Alliance & Intervention Satisfaction [28] | - | √ | - |